HC ANDERSEN CAPITAL

Main Menu

HC ANDERSEN CAPITAL

INDERES
CONTACT

ExpreS2ion Biotechnologies – Update on EU-funded Nipah virus vaccine project

AUTHOR
DATE
14. december 2023
CATEGORY

ExpreS2ion Biotechnologies – Update on EU-funded Nipah virus vaccine project

ExpreS2ion Biotechnologies – Update on EU-funded Nipah virus vaccine project 14 DecemberDec 2023 10:00 - 10:30Online Event
Register

Information

ExpreS2ion Biotechnologies – Update on EU-funded Nipah virus vaccine project 14 DecemberDec 2023 10:00 - 10:30
ExpreS2ion Biotechnologies – Update on EU-funded Nipah virus vaccine project Online Event
Register

PREVIOUS STORY

NEXT STORY

Explore our services

IR Advisory

Read more

ESG Advisory

Read more

Legal Advisory

Read more

Corporate Finance

Read more

IR Recruitment

Read more

Certified Advisor (CA)

Read more

Commissioned Research

Read more

HCA Media

Read more

IR Distribution Software

Read more

AGM Services

Read more

IR Events

Read more

IR Websites

Read more

Digital IR

Read more

HC ANDERSEN CAPITAL

INFORMATION

Bredgade 23B 2. sal
1260 København K
View on map
Phone: 28 74 66 40
CVR: 41474793

About

What we do

HC Andersen Capital was established in 2020 and is at the forefront of digital Investor Relations, amplifying market presence.

Our tailored services encompass IR and ESG advisory, Legal Support, cutting-edge digital solutions such as IR websites and IR distribution software, Commissioned Research, Corporate Finance advisory and more. We are proudly Certified Advisor on Nasdaq First North Copenhagen.

2024 - HC Andersen Capital

Cookie Policy

Privacy Policy